Intraoperative radiotherapy (IORT) business to Carl Zeiss Meditec struggled with growth since the (A) case. Although the unit revenues increased by more than 50% and EBIT exceeded his goal, he was faced with a number of key strategic decisions. Whether it should continue to specialize in a segment of breast cancer, or whether it should focus more on operations with radiation therapy as a single solution. Whether it should continue to focus on the more mature markets, or whether it should make targeted investments in emerging markets? (A) case is of IORT as a disruptive technology, and (B) if the instructor offers the opportunity to assess the progress made by the main character in the application of this framework. "Hide
by Willy Shih Source: Harvard Business School 4 pages. Publication Date: September 25, 2012. Prod. #: 613040-PDF-ENG
Related Case Solutions & Analyses:
Supply Chain Management at International Automotive
Mirae Asset: Koreas Mutual Fund Pioneer
Silver Stars North American Flight Center
Paragon Corporation and Its Flight Department
Unicon Concrete Products (H.K.) Ltd.
Driving Towards a Disruption?
Overview of Service Design in the Performing Arts
Digital Certificates and Signatures: Microsoft Corp.
Father’s Love: Novazyme Pharmaceuticals, Inc.
EMMICO: How to Establish Economic Order Quantity
